Halozyme Therapeutics | HALO - Ebit





Ebit Changement Date
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amarin USD -2.26M 564K 2025-12
Amgen USD 4.61B 777M 2026-06
Baxter International USD 276M 210M 2026-06
Cara Therapeutics USD -7.05M 1.11M 2026-03
Cytokinetics USD -179.17M 2.05M 2026-06
DBV Technologies USD -47.9M 2.85M 2026-03
Eli Lilly USD 12.46B 2.68B 2026-06
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
MannKind USD -68.23M 8.76M 2026-06
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Pfizer USD -180M 5.16B 2026-06
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
United Therapeutics USD 375.6M 49.8M 2026-06
Vanda Pharmaceuticals USD -10.28M 721K 2024-12